Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro.
about
Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7Misregulation of pre-mRNA alternative splicing in cancerThe role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progressionAlternative pre-mRNA splicing regulation in cancer: pathways and programs unhingedLong non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1)Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations.High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin.Translational research in the Gynecologic Oncology Group: evaluation of ovarian cancer markers, profiles, and novel therapies.Concordance of deregulated mechanisms unveiled in underpowered experiments: PTBP1 knockdown case studyMicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblastsLong non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complexHydrogen peroxide alters splicing of soluble guanylyl cyclase and selectively modulates expression of splicing regulators in human cancer cells.A high-throughput assay to identify small-molecule modulators of alternative pre-mRNA splicing.Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer.Elevated expression of the serine-arginine protein kinase 1 gene in ovarian cancer and its role in Cisplatin cytotoxicity in vitroPolypyrimidine tract-binding protein induces p19(Ink4d) expression and inhibits the proliferation of H1299 cells.Identification of cis-acting elements and splicing factors involved in the regulation of BIM Pre-mRNA splicingThe perinucleolar compartment: RNA metabolism and cancerSplicing programs and cancerThe polypyrimidine tract binding protein regulates desaturase alternative splicing and PUFA composition.Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repairNeuronal regulation of pre-mRNA splicing by polypyrimidine tract binding proteins, PTBP1 and PTBP2.LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis.The impact of RNA binding motif protein 4-regulated splicing cascade on the progression and metabolism of colorectal cancer cells.Regulation and functional significance of CDC42 alternative splicing in ovarian cancerPTBP1-associated microRNA-1 and -133b suppress the Warburg effect in colorectal tumors.Tannic acid facilitates expression of the polypyrimidine tract binding protein and alleviates deleterious inclusion of CHRNA1 exon P3A due to an hnRNP H-disrupting mutation in congenital myasthenic syndromeProgress in microRNA delivery.Involvement of polypyrimidine tract-binding protein (PTBP1) in maintaining breast cancer cell growth and malignant properties.Polypyrimidine Tract-Binding Protein 1 promotes proliferation, migration and invasion in clear-cell renal cell carcinoma by regulating alternative splicing of PKMTurning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA.New insights into functional roles of the polypyrimidine tract-binding protein.Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB.Splicing-factor alterations in cancers.Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits.RNA processing as an alternative route to attack glioblastoma.PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis.Tumor metabolism: hnRNP proteins get in on the actUpregulated c-myc expression in multiple myeloma by internal ribosome entry results from increased interactions with and expression of PTB-1 and YB-1.HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer.
P2860
Q24646831-ECB37DA8-AB91-446A-8085-6F2CEAB9777CQ27007114-3FBF74A0-B92F-4CBB-9023-41CE03A5A14CQ28083838-B887CF41-1E68-46BB-94EC-D2F7E14EB049Q28297381-8F5D0939-E5C9-4A2C-9E91-4FCF08B3C044Q33695009-3370DB82-4903-4B69-9372-F4FD82AEBFB7Q33778961-D2438B43-AB3B-4C8E-BD93-EE4AFF0A4146Q33829442-FC123697-659E-4386-9973-0C85FA4BCDFBQ33880468-6C8F8964-E98E-4006-80BF-A7DC4C44420DQ33912819-3B0C4D1F-5662-43D9-AB8A-1C7FD9F88863Q33982509-EE01DBE3-0A4D-4E7F-A3DD-53F11FF25DCBQ34051999-DB0357D3-95A2-4463-8BC1-8A2DAB485489Q34387675-C185EAD9-C5D0-4A7C-B0B0-9081DC998ABBQ34413536-156AE361-AD2B-46EA-980A-2959F16B283FQ34441008-D35AC54D-5ECF-4570-8C8E-697A12EE3E52Q34510663-2C3F4936-844F-4E48-8DED-E7B25E306BB8Q34639195-316A39F4-593D-40E3-BC48-DDB522985250Q35151577-C2CD8B85-54A9-474F-ADD2-5E3C5CE1C69BQ35218889-68C33AC4-E381-47F2-9DAB-6C31C1D9E7EFQ35450183-825E2A54-AF37-49D2-960E-CA6AA30FB733Q35561990-E4D07723-7740-4B01-A8E4-C0F28579903CQ35965275-C5BCE013-6259-4D7D-A6AF-2923DC584E48Q36174640-71D5A16E-0FAD-459A-9432-F95D480EE535Q36179588-4CB65F43-CA48-4EA7-87DC-B69107F88101Q36545961-4A92F885-43E8-47D1-A395-C843C4FA4E3CQ36557397-E0CE2034-B723-427D-B468-97CC05B9FB6FQ37109902-B03F4246-372E-468E-A1C8-46F1A5F96C72Q37128363-8CB44998-7C26-41F5-81AD-CAA799C85EAEQ37478933-BC50CCF3-C92D-416F-9BA0-4C5122186F2EQ37614600-D2135735-2855-447A-B82B-73143D3807EAQ37679992-B89B4440-9FF4-431C-8F8D-C4EDF8E4D30EQ37803300-D323A98E-BAB3-487A-826D-5C8599C3305CQ38165048-404D1FDB-3066-4B11-BFC2-E6F6CB7B4386Q38341668-F44D97AA-A2B4-4AF0-BF31-532AF089F256Q38929098-9D2E5617-1A1A-4E21-B2C5-BA46104667D2Q39211798-BE1456C3-4A3D-45D1-BF8E-AA55051CE39BQ39368650-D5E83864-9898-4C27-B7FC-FC38D035DB5DQ39462691-AA9DBE54-83E1-494C-804C-3103533FACB0Q39699927-0602E004-867D-48FE-B9DA-3232FC2EC9D0Q39733957-8FDF611A-6443-4384-A02B-F89B670E5DA5Q39763266-75E22152-C195-4F60-8AB1-A0C3C992D3EE
P2860
Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Knockdown of polypyrimidine tr ...... wth and invasiveness in vitro.
@ast
Knockdown of polypyrimidine tr ...... wth and invasiveness in vitro.
@en
type
label
Knockdown of polypyrimidine tr ...... wth and invasiveness in vitro.
@ast
Knockdown of polypyrimidine tr ...... wth and invasiveness in vitro.
@en
prefLabel
Knockdown of polypyrimidine tr ...... wth and invasiveness in vitro.
@ast
Knockdown of polypyrimidine tr ...... wth and invasiveness in vitro.
@en
P2093
P2860
P356
P1433
P1476
Knockdown of polypyrimidine tr ...... wth and invasiveness in vitro.
@en
P2093
N Auersperg
P2860
P2888
P304
P356
10.1038/SJ.ONC.1210307
P407
P577
2007-02-19T00:00:00Z
P5875
P6179
1007373042